J Korean Soc Pediatr Nephrol > Volume 9(2); 2005 > Article
Journal of the Korean Society of Pediatric Nephrology 2005;9(2): 275-281.
소아에서 신장 이식 후 발생한 Parvovirus Bl9 감염 2례
구소은, 이주훈, 한혜원, 한덕종, 박영서
1울산대학교 의과대학 서울아산병원 소아과
2울산대학교 의과대학 서울아산병원 소아과
3을지의과대학교 소아과학교실
4울산대학교 의과대학 서울아산병원 외과
5울산대학교 의과대학 서울아산병원 소아과
Parvovirus B19 Infection in Two Korean Pediatric Kidney Transplant Patients
So-Eun Koo, Joo-Hoon Lee, Hye-Won Hahn, Duck-Jong Han, Young-Seo Park
1Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine
2Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine
3Department of Pediatics, Eulji University School of Medicine
4Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine
5Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine
Share :  
Parvovirus B19(PV B19) is a nonenveloped single-stranded DNA virus that causes a wide variety of diseases ranging from benign childhood infection such as slapped-cheek rash(fifth disease) to life threatening diseases such as hydrous fetalis in fetuses or aplastic anemic crises in patients with hemolytic anemia. In immunocompromised hosts including organ transplant recipients, this infection can cause chronic anemia. Recently, the reports of cases of PV B19 infection have been increasing in transplant recipients and most reported cases of PV B19 infection-associated anemia in renal transplant recipients were successfully treated with intravenous immunoglobulin infusion. We experienced two cases of aplastic anemia caused by PV B19 infection in pediatric renal transplant recipients. The patients were an 8 year-old boy and 12-year-old boy who received allograft kidneys from their mothers. Anemia developed 2 weeks after transplantation and their serum was positive for PV B19 PCR. They were treated with 400 mg/kg of intravenous immunoglobulin(IVIG) for 5 consecutive days. In one of the case, anemia was corrected promptly after the first 5-day course of IVIG therapy but in the other, anemia persisted but responded to the second course of IVIG therapy. One year later, the patients have normal hematocrit levels and stable renal function These are the first cases of PV B19 infection treated successfully with IVIG in pediatric renal transplant recipients in Korea. (J Korean Soc Pediatr Nephrol 2005;9:275-281)
Key words: Parvovirus Bl9 | Kidney transplantation | Immunoglobulin | Children

Editorial Office
240, Gimpohangang 1-ro, Gimpo-si, Gyeonggi-do, 10078, Republic of Korea
TEL: +82-10-4391-0788   E-mail: chikd@chikd.org
Copyright© Korean Society of Pediatric Nephrology.         
Close layer